Results

Total Results: 1,494 records

Showing results for "harms".

201. Dispostion of Comments Report for Child and Adolescent Exposure to Trauma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-child-interventions_disposition-comments.pdf
     February 11, 2013 - Greater attention to assessment of risk of harms and harms/benefits is merited and may suggest the need … We have included KQ4 as our assessment of harms in the included studies. … We did not find many studies to report harms. … We do make an effort to weigh these harms with the potential benefits. … .”The distinction between no evidence of harms and evidence of lack of harms is made in the Methods

202. Comparative Effectiveness of Strategies to De-escalate Aggressive Behavior in Psychiatric Patients in Acute Care Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_executive.pdf
     October 01, 2016 - We view effectiveness in terms of both benefits and harms, so we frame our questions to address each … KQ 3 addresses specific patient, intervention, or setting factors that may modify benefits or harms … KQ 2: Regarding harms for adult psychiatric patients in acute care settings: a. … For those with active aggression, what are the comparative harms of strategies, including seclusion … of prevention), one CRT; and KQ 2b (harms of de-escalating aggression), four RCTs and two NRCTs.

203. Disposition of Comments Report for Otitis Media With Effusion (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_disposition-comments.pdf
     May 04, 2013 - We were able to observe harms within this literature base. … Suggested change: The issue of harms/adverse events of tubes vs. … We have examined short v. long term tubes in terms of benefit and harms. … Because many of the studies were small, harms data is sparse. … We have revised the results concerning harms from adenoidectomy.

204. Evidence Summary: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-evidence-summary_0.pdf
     October 01, 2019 - in Adult Patients With Exacerbation of COPD Purpose of Review To evaluate the effectiveness and harms … , the benefits and harms of treatments for ECOPD that have been found efficacious in stable COPD , … the benefits and harms of antibiotics and systemic corticosteroids in mild ECOPD, the benefits and … In adult patients with exacerbation of COPD, what are the benefits and harms of emerging and other … In adult patients with exacerbation of COPD, what are the benefits and harms of emerging and other

205. Amended Protocol: Management of Infantile Epilepsy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-epilepsy-amended-protocol.pdf
     March 07, 2021 - What are the harms or comparative harms of treatments for infantile epilepsy? … Timing Effectiveness: 12 week minimum follow-up Harms: No minimum follow-up Setting Setting not … What are the harms or comparative harms of not treating infantile epilepsy? … For Key Question 3 (harms), we will include single-arm studies as well as controlled studies. 6. … However, for harms data, we will extract data from all reported time points.

206. Searching for Relevant Studies (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/searching.ppt
     January 01, 2011 - Efficacy and harms searches may be separate. … intervention and harms and/or disease. … In a harms search, including just the intervention and harms may be permissible. … Harms Searching To make informed health care decisions, the balance of benefits to harms needs to be … This can be important for determining efficacy and harms.

207. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-loss-surgery_research-protocol.pdf
     December 14, 2010 - This review should help 1) better understand long-term benefits and harms associated with different … Outcome measures for harms, or adverse events, are the same as in KQ3, and KQ5 below. … First, by using data from clinical trials and large cohort studies, evidence of benefits and harms of … Documented short- and long-term benefits and harms of surgical procedures will be compared too; the … Benefits and harms for specific subpopulations (by gender, age, and race/ethnicity) and other patient

208. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update--Executive Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
     January 01, 2018 - been a near disappearance of the use of FGAs Purpose of Review: To assess the effectiveness and harms … Harms (KQ2) were reported in 126 studies (93%). … Several studies found no significant differences in harms for different age groups. … Treatment benefit and harms were examined most frequently for schizophrenia. … One of the greatest priorities for future research is the systematic evaluation of harms.

209. Public-Reporting-Quality-Improvement Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-quality-improvement_executive.pdf
     July 01, 2012 - Key Question 2 What harms result from public reporting? … Harms are another potential consequence of public reporting (Key Question 2). … Key Question 2: What harms result from public reporting? … Studies that examined harms found more evidence of no harm than evidence of harm. … harms is limited and most studies do not confirm the potential harm.

210. Amendment_HIE-Protocol_3-14-2015 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-information-exchange_research-protocol.pdf
     April 20, 2015 - What harms have resulted from HIE? … Do harms vary by type of HIE? 2b. Do harms vary by health care settings and systems? 2c. … Do harms vary by the IT system characteristics? 3. … What specific usability factors impact the effectiveness or harms from HIE? 5c. … KQ 2 Harms KQ 2 Intermediate outcomes Harms KQ 2 Source: www.effectivehealthcare.ahrq.gov

211. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_executive.pdf
     September 01, 2009 - ; and examine how benefits and harms vary by age, breast cancer risk status, and other factors. … What is the evidence for harms of tamoxifen citrate, raloxifene, and tibolone when used to reduce risk … What is the evidence that harms or secondary potential benefits listed above affect treatment choice, … Harms of tamoxifen citrate, raloxifene, and tibolone when used for primary prevention of breast cancer … : • In addition to the 8 large randomized controlled trials described in Key Question 1, harms data

212. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
     March 13, 2012 - How do these harms vary by dose or formulation, duration of use, or specific population? … KQ 6: Based on the comprehensive literature review, what are the benefits and harms from the use of … While on OCs, women are at risk for both short- and long-term harms, some of which may be fatal. … How do these harms vary by dose or formulation, duration of use, or specific population? … How do these harms vary by dose or formulation, duration of use, or specific population?

213. Abnormal-Uterine-Bleeding Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/abnormal-uterine-bleeding_research-protocol.pdf
     November 21, 2011 - Key Question 2: What are the harms, including adverse events, associated with medical, behavioral, … 2 (e.g., thromboembolic events, emotional side effects, weight gain, short- and long-term harms) … conception  Additional interventions Interventions  Medical  Behavioral  CAM Harms … conducting a systematic review of harms data. 43 As a meta-analysis is not likely to be feasible … Challenges in systematic reviews that assess treatment harms.

214. Use of Observational Studies in Systematic Reviews of (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguidenorris_060420101.pdf
     June 01, 2010 - Reviews are systematic reviews of existing research on the effectiveness, comparative effectiveness, and harms … on the efficacy or effectiveness of a single intervention, by comparing the relative benefits and harms … The inception date also allows investigators to capture the benefits and harms that occurred after a … A potential advantage of this type of study is that long- term benefits, tolerability, and harms can … AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the Effective

215. Use of Observational Studies in Systematic Reviews of (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
     June 01, 2010 - Reviews are systematic reviews of existing research on the effectiveness, comparative effectiveness, and harms … on the efficacy or effectiveness of a single intervention, by comparing the relative benefits and harms … The inception date also allows investigators to capture the benefits and harms that occurred after a … A potential advantage of this type of study is that long- term benefits, tolerability, and harms can … AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the Effective

216. Renal-Cancer Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_executive.pdf
     February 01, 2016 - Harms 12 Low A small, but notable, proportion of patients experience harms due to renal mass biopsy, … Studies were inconsistent in which harms, if any, were reported. Table C. … Harms 16 Low A small, but notable, proportion of patients experience harms due to renal mass biopsy, … Studies were inconsistent in which harms, if any, were reported. … Harms were evaluated as urologic and nonurologic complications.

217. Topic Brief: Nonpharmacologic Treatment of Mental Health Conditions in Pregnant and Postpartum People (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/nt_docs/1002-nonpharmacologic-treatment-topic-brief.pdf
     June 03, 2024 - Issue: The nominator of this topic is interested the benefits and harms of nonpharmacologic treatments … What is the effectiveness and comparative effectiveness and harms of non-pharmacologic treatments for … mental health conditions prompts questions about the benefits and harms of nonpharmacologic treatment … Incorporates issues around both clinical benefits and potential clinical harms Yes 2d. … , fetal/neonatal/child harms 2.

218. Liver-Cancer Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer_research-protocol.pdf
     July 24, 2013 - What are the adverse effects or harms associated with imaging-based surveillance strategies? … What are the adverse effects or harms associated with using imaging techniques related to testing or … o Key Questions 1d, 2d, and 3d (Adverse Events or Harms)  Adverse effects or harms associated with …  Adverse effects or harms associated with test-associated diagnostic workup (e.g., harms of biopsy … or harms associated with workup of other incidental tumors discovered on imaging)

219. Can Physical Activity Improve the Health of Wheelchair Users? Amended Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/wheelchair-users-amended-protocol.pdf
     June 21, 2019 - The objective is to understand the benefits and harms of physical activity for people currently using … Does physical activity reduce the harms of immobility, such as incidence of decubitus ulcer, urinary … What are the harms of physical activity, such as injuries that are associated with wheeled mobility … Do the benefits or harms of physical activity vary by the location of the intervention (e.g., home, … Do the benefits and harms of physical activity vary by age, sex, or race/ethnicity? b.

220. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
     May 01, 2010 - • Are there patient subpopulations where harms are more likely? … Regarding the benefits and harms of rFVIIa, our findings include: Figure C. … • Current evidence of low strength is too limited to compare harms and benefits. … • Current evidence is insufficient for comparing harms and benefits. … • Current evidence is insufficient for comparing harms and benefits.